BUY Indian Energy Exchange — Rajesh Satpute
byRajesh SatputeHorizon: Intraday2 Nov 2026, 9:54 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
IEX Buyback Back On The Table? Board Evaluates Ways To Reward Shareholders
NewsNdtv-Profit·30 Oct · 2d ago
Indian Energy Exchange reported consolidated PAT of Rs 274.0 crore for H1 FY27, a 12.3% increase year-on-year, with Q2 FY27 PAT at Rs 139.2 crore, up 12.9% year-on-year.
BSE · Company Update·29 Oct · 3d ago
Indian Energy Exchange reported standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showing growth in profit for the period.
BSE · Board Meeting·29 Oct · 3d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Indian Energy Exchange
- BUY — Manas Jaiswal3 Nov 2026 · ~2 weeks · target ₹112 · Target hit
- BUY — Elara Capital2 Nov 2026 · ~1 year · target ₹117 · Active
- BUY — Mehul Kothari, Anand Rathi29 Oct 2026 · ~2 weeks · target ₹112 · SL hit
- BUY — Manas Jaiswal7 Oct 2026 · ~2 weeks · target ₹112 · SL hit
- BUY — Bernstein7 Oct 2026 · ~1 year · target ₹110 · Target hit
More from Rajesh Satpute
- BUY Zensar Technologies6 Nov 2026 · ~2 weeks · target ₹610 · Active
- BUY Karur Vysya Bank6 Nov 2026 · Same day · target ₹370 · Target hit
- BUY SBI Life Insurance Company5 Nov 2026 · Same day · target ₹1,760 · Expired
- BUY One 97 Communications5 Nov 2026 · ~2 weeks · target ₹1,850 · Active
- BUY Mankind Pharma5 Nov 2026 · Same day · target ₹2,600 · SL hit

